Lyell ImmunopharmaLYEL
13F holders, Q2 2025 (June 30)64holders
3famous investors
$8.84avg. 13F price*
At the end of Q2 2025, 64 institutions reported holding Lyell Immunopharma Inc. (LYEL) in their 13F filings. The largest holders were ARCH Venture Management, LLC ($16.1M), Foresite Capital Management IV, LLC ($7.1M) and Almitas Capital LLC ($5.1M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lyell Immunopharma Inc.
- CUSIP
- 55083R203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $19.0M |
| Exits | 1 | $126K |
Ownership 64 holders
| ARCH Venture Management, LLC | 5.39% | New | 1,820,634 | $16.1M |
| Foresite Capital Management IV, LLC | 5.72% | No change | 800,399 | $7.1M |
| Almitas Capital LLC | 1.30% | Add +367.3% | 579,997 | $5.1M |
| venBio Partners LLC | 3.65% | Add +33.3% | 473,479 | $4.2M |
| Vanguard Group Inc. | 0.00% | Reduce -9.1% | 442,626 | $3.9M |
| Foresite Capital Management V, LLC | 4.45% | No change | 406,652 | $3.6M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -5.5% | 306,059 | $2.7M |
| Alphabet Inc. | 0.12% | No change | 293,256 | $2.6M |
| Citadel Advisors | 0.00% | Add +20.4% | 271,283 | $2.4M |
| HSG Holding Ltd | 0.07% | No change | 152,299 | $1.3M |
| BlackRock, Inc. | 0.00% | Reduce -77.2% | 144,859 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Reduce -53.0% | 103,270 | $913K |
| RBF Capital, LLC | 0.04% | New | 100,000 | $884K |
| Woodline Partners LP | 0.00% | New | 98,425 | $870K |
| MIC Capital Management UK LLP | 0.15% | No change | 87,028 | $769K |
| Renaissance Technologies | 0.00% | Reduce -24.0% | 67,190 | $594K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -23.4% | 61,503 | $544K |
| Millennium Management | 0.00% | Add +2331.7% | 52,229 | $462K |
| Orbimed Advisors LLC | 0.01% | New | 51,727 | $457K |
| TD Asset Management Inc | 0.00% | No change | 50,232 | $444K |
| Ikarian Capital, LLC | 0.13% | No change | 43,799 | $387K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Add +41.8% | 39,621 | $350K |
| State Street Corp. | 0.00% | Reduce -81.7% | 33,847 | $299K |
| Canada Pension Plan Investment Board | 0.00% | No change | 29,411 | $260K |
| Walleye Capital LLC | 0.00% | New | 29,230 | $258K |
| Acadian Asset Management LLC | 0.00% | Reduce -17.2% | 27,366 | $241K |
| Morgan Stanley | 0.00% | Reduce -40.7% | 25,698 | $227K |
| UBS Group AG | 0.00% | Add +364.4% | 25,634 | $227K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -5.0% | 24,419 | $216K |
| Bank of America Corp. | 0.00% | Add +405.1% | 23,758 | $210K |
| Susquehanna Portfolio Strategies, LLC | 0.00% | New | 21,700 | $192K |
| Clarius Group, LLC | 0.01% | Reduce -4.1% | 19,138 | $169K |
| Northern Trust Corp. | 0.00% | Reduce -71.2% | 18,644 | $165K |
| Bridgeway Capital Management, LLC | 0.00% | New | 18,000 | $159K |
| Invesco Ltd. | 0.00% | Reduce -32.4% | 12,809 | $113K |
| Boothbay Fund Management, LLC | 0.00% | No change | 12,234 | $108K |
| Marshall Wace, LLP | 0.00% | New | 10,580 | $94K |
| Two Sigma Investments, LP | 0.00% | Reduce -48.1% | 10,059 | $89K |
| Raymond James Financial Inc. | 0.00% | No change | 7,900 | $70K |
| JPMorgan Chase & Co. | 0.00% | Reduce -65.4% | 3,369 | $30K |
| FMR LLC | 0.00% | Add +218.3% | 3,077 | $27K |
| China Universal Asset Management Co., Ltd. | 0.00% | Add +1.2% | 2,966 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +73.3% | 2,103 | $19K |
| Citigroup Inc. | 0.00% | Reduce -65.1% | 2,055 | $18K |
| Jones Financial Companies LLLP | 0.00% | No change | 2,000 | $18K |
| Wells Fargo & Company | 0.00% | Reduce -59.1% | 1,970 | $17K |
| Barclays PLC | 0.00% | Reduce -87.4% | 1,155 | $10K |
| Advisors Asset Management, Inc. | 0.00% | Reduce -1.0% | 575 | $5K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +16.6% | 570 | $5K |
| Cwm, LLC | 0.00% | Reduce -28.2% | 415 | $4K |
| BNP Paribas Financial Markets | 0.00% | Reduce -95.8% | 353 | $3K |
| Shell Asset Management Co. | 0.00% | No change | 320 | $3K |
| VSM Wealth Advisory, LLC | 0.00% | No change | 250 | $2K |
| Simplex Trading, LLC | 0.00% | Add +502.0% | 298 | $2K |
| MAI Capital Management | 0.00% | No change | 100 | $884 |
| US Bancorp \de | 0.00% | Reduce -0.4% | 58 | $513 |
| GAMMA Investing LLC | 0.00% | New | 35 | $309 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 25 | $221 |
| True Wealth Design, LLC | 0.00% | Add +666.7% | 23 | $204 |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -92.1% | 4 | $35 |
| IFP Advisors, Inc | 0.00% | New | 3 | $27 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -81.1% | 1 | $9 |
| Royal Bank of Canada | 0.00% | Reduce -97.5% | 25 | $0 |
| Daiwa Securities Group Inc. | 0.00% | Reduce -1.9% | 45 | $0 |
"% of holder's portfolio" is LYEL's weight in each manager's 13F, not the share of Lyell Immunopharma Inc. the manager owns.